Stock Updates

How has Allergan plc performed recently?

Allergan plc (NYSE: AGN) is a large market cap stock with a market cap of 79292.07. It is in the Drugs – Generic industry and sector Healthcare, with a current P/E of *TBA, a forward P/E of 13.2 and EPS of -3.12. At a stock price of 236.34 (0.84%) it has a dividend yield of 1.18%.


EPS growth for the last five years have been -28.70%, more recently this last year it has grown by 63.30%. The next year growth is going to be about 11.70% and more long-term 13.81% after five years. EPS growth quarter over quarter is 85.60%. Sales growth for the past five years have been 26.00% and sales growth quarter over quarter is 7.10%.

For performance, Allergan plc the past week has seen a gain of -1.16%. For the last month performance for Allergan plc is -0.26%. While the last quarter is 9.44% and half year, 5.81%. Finally for the year, performance is 5.03%.

The 52-week high for Allergan plc, is at -9.28%, and for the 52-week low it comes to a value of 28.46%. The 20-day simple moving average is -0.65% and 3.57% for the 200-day simple moving average.

Volatility for the week is at 1.18%, and for the month it is 1.33%. Allergan plc, has a target price of 268.67.

In terms of debt, long term debt/equity is 0.42, and for total debt/equity Allergan plc has 0.47. The gross margin is 87.20%, while operating margin is -12.50%, the profit margin is *TBA. The current ratio is 2.3 and the quick ratio is 2.2.

Insider ownership is at 0.20%, with instituitional ownership at 93.00%. Allergan plc has a payout ratio of 0.00%. With the total shares outstanding coming to 335.5. The shares float is 334.81, with the float short at 3.37%, with short ratio coming to 3.76.

In terms of returns, the return on assets see Allergan plc, get 10.90%, with its returns on investment at 0.10%. Return on equity is 19.60%. So will the investors see the target price of 268.67, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

 Allergan plc (NYSE: AGN)

About the author

Peter Clarke

Leave a Comment